Aquestive Therapeutics AQST
$3.46 −$0.25 (-6.61%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.52 +1.73%
Open$3.62
Prev close$3.71
Day range$3.41 – $3.65
Volume3.36M
Market cap$434.88M
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts4
Average target$9.25+167.3% vs. price
- Buy 100%
Low $6.00Now $3.46Avg $9.25High $11.00
Recent rating changes
The last 20 actions on file set price targets from $6.00 to $11.00, averaging $9.00.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 9 Nov 2026 | H.C. Wainwright | BUY | $10.00 |
| 5 Nov 2026 | Leerink Partners | BUY | $11.00 |
| 16 Oct 2026 | H.C. Wainwright | BUY | $10.00 |
| 15 Oct 2026 | H.C. Wainwright | BUY | $10.00 |
| 21 Sep 2026 | H.C. Wainwright | BUY | $10.00 |
| 17 Sep 2026 | LifeSci Capital | BUY | $10.00 |
| 17 Sep 2026 | Lake Street | BUY | $6.00 |
| 24 Aug 2026 | H.C. Wainwright | BUY | $10.00 |
| 13 Aug 2026 | LifeSci Capital | BUY | $10.00 |
| 10 Aug 2026 | LifeSci Capital | BUY | $10.00 |
| 10 Aug 2026 | Lake Street | BUY | $6.00 |
| 25 Jun 2026 | Cantor Fitzgerald | BUY | $11.00 |
| 25 Jun 2026 | Chardan Capital | BUY | $8.00 |
| 25 Jun 2026 | LifeSci Capital | BUY | $9.00 |
| 15 May 2026 | LifeSci Capital | BUY | $9.00 |
| 15 May 2026 | Piper Sandler | BUY | $8.00 |
| 15 May 2026 | Leerink Partners | BUY | $9.00 |
| 15 May 2026 | Lake Street | BUY | $6.00 |
| 15 May 2026 | Oppenheimer | BUY | $8.00 |
| 14 May 2026 | A. G. P. | BUY | $9.00 |
No comments yet — be the first to weigh in on AQST.
Sign in to join the discussion.